Healthcare · Pharmaceutical spending per capita

Pharmaceutical spending per capita in Canada in 2026

Canada is among the top five global leaders in per capita pharmaceutical spending, reaching 950 $ in 2026. This high expenditure is driven by the cost of innovative drugs, widespread private insurance coverage, and an aging population. The bulk of sales occurs through pharmacy chains in Ontario and Quebec, home to a third of all Canadians. In 2026, Canada ranks 5-th out of 197, highlighting the size and high monetization of its national pharmaceutical market.

Data for 2026 · unit: $
Position

Canada world ranking

#5 / 197

Country position on the scale from last to first place for this indicator.

CA
#5
#197#1
Trend

Change over time

Change in indicator over the available period.

350
1990
550
2000
750
2010
900
2020
950
2026

Values — $

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical spending per capita in Canada — how much?
Based on 2026 data — 950 $. This is rank #5 out of 197 countries.
What is Canada's rank by Pharmaceutical spending per capita?
Canada ranks #5 out of 197 countries in the world ranking by «Pharmaceutical spending per capita».
How has Pharmaceutical spending per capita changed in Canada?
Over the available period the indicator changed from 350 to 950 $.